申请人:Isis Pharmaceuticals Inc.
公开号:US20040077567A1
公开(公告)日:2004-04-22
Antisense compounds, compositions and methods are provided for modulating the expression of CD36. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding CD36. Methods of using these compounds for modulation of CD36 expression and for treatment of diseases associated with expression of CD36 are provided.
提供了用于调节CD36表达的反义物质、组合物和方法。这些组合物包括针对编码CD36的核酸的反义物质,特别是反义寡核苷酸。提供了利用这些化合物调节CD36表达和治疗与CD36表达相关疾病的方法。